Emodin plays an interventional role in epileptic rats via multidrug resistance gene 1 (MDR1)

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 3, 2015, Pages 3418-3425

  Yang, Tao ^a,b   Kong, Bin ^a,b   Kuang, Yongqin ^a   Cheng, Lin ^a   Gu, Jianwen ^a   Zhang, Junhai ^a   Shu, Haifeng ^a   Yu, Sixun ^a   Yang, Xiaokun ^a,b   Cheng, Jingming ^a   Huang, Haidong ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Animal model; Emodin; Epilepsy; MDR1 gene

Indexed keywords

ANTICONVULSIVE AGENT; CYCLOOXYGENASE 2; EMODIN; KAINIC ACID; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PTGS2 PROTEIN, RAT;

ANIMAL; ANIMAL BEHAVIOR; BRAIN; CHEMICALLY INDUCED; CONFOCAL MICROSCOPY; DISEASE MODEL; DRUG EFFECTS; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GENETICS; METABOLISM; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WISTAR RAT;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN WAVES; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EMODIN; EPILEPSY; FEMALE; KAINIC ACID; MICROSCOPY, CONFOCAL; P-GLYCOPROTEINS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84933033898     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Saygi S, Alehan F, Atac FB, Erol I, Verdi H and Erdem R. Multidrug resistance 1 (MDR1) 3435C/T genotyping in childhood drug-resistant epilepsy. Brain Dev 2014; 36: 137-142.
2. Ban JJ, Jung KH, Chu K, Lee ST, Jeon D, Park KI, Moon HJ, Kim H, Kim S, Lee SK and Roh JK. Profiles of multidrug resistance protein-1 in the peripheral blood mononuclear cells of patients with refractory epilepsy. PLoS One 2012; 7: e36985.
3. Lazarowski A and Czornyj L. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions. Drug Metabol Drug Interact 2011; 26: 21-26.
4. Das A, Wallace GC 4th, Holmes C, McDowell ML, Smith JA, Marshall JD, Bonilha L, Edwards JC, Glazier SS, Ray SK and Banik NL. Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors. Neuroscience 2012; 220: 237-246.
5. Srinivas G, Babykutty S, Sathiadevan PP and Srinivas P. Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent. Med Res Rev 2007; 27: 591-608.
6. Trimble M. Treatment issues for personality disorders in epilepsy. Epilepsia 2013; 54: 41-45.
7. Nakken KO, Sætre E, Markhus R and Lossius MI. [Epilepsy in the elderly]. Tidsskr Nor Laegeforen 2013; 133: 528-531.
8. Hesdorffer DC, Beck V, Begley CE, Bishop ML, Cushner-Weinstein S, Holmes GL, Shafer PO, Sirven JI and Austin JK. Research implications of the Institute of Medicine Report, Epilepsy Across the Spectrum: Promoting Health and Understanding. Epilepsia 2013; 54: 207-216.
9. Bialecka M, Hnatyszyn G, Bielicka-Cymerman J and Drozdzik M. [The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy]. Neurol Neurochir Pol 2005; 39: 476-481.
10. Seven M, Batar B, Unal S, Yesil G, Yuksel A and Guven M. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children. Mol Biol Rep 2014; 41: 331-336.
11. Ishikawa T, Sakurai A, Hirano H, Lezhava A, Sakurai M and Hayashizaki Y. Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1). Pharmacol Ther 2010; 126: 69-81.
12. Kaya M, Becker AJ and Gürses C. Blood-brain barrier, epileptogenesis, and treatment strategies in cortical dysplasia. Epilepsia 2012; 53: 31-36.
13. Lee YS, Lee SJ, Seo KW, Bae JU, Park SY and Kim CD. Homocysteine induces COX-2 expression in macrophages through ROS generated by NMDA receptor-calcium signaling pathways. Free Radic Res 2013; 47: 422-431.
14. Yousif S, Chaves C, Potin S, Margaill I, Scherrmann JM and Declèves X. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation. J Neurochem 2012; 123: 491-503.
15. Potschka H. Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies? Epilepsia 2010; 51: 1333-1347.